Literature DB >> 24643510

Serum IL-10 involved in morphine tolerance development during adjuvant-induced arthritis.

Jalal Zaringhalam1, Asef Hormozi, Elaheh Tekieh, Jafar Razavi, Ramin Khanmohammad, Sahar Golabi.   

Abstract

Opioid receptors play an important role in modulation of hyperalgesia in inflamed tissues, but chronic morphine application induces such side effects as tolerance. There is near communications between cytokines and mu opioid receptor expression. This study was aimed to assess the role of serum IL-10 in morphine tolerance development during adjuvant-induced arthritis. Adjuvant arthritis (AA) was induced on day 0 by single injection of Complete Freund's Adjuvant (CFA) into the rats' hindpaw. Hyperalgesia, edema, and spinal mu opioid receptor (mOR) variations were assessed on 0, 7, 14, and 21 days of the study. For assessment of the morphine tolerance development, morphine effective dose (4 mg/kg) was administered from the 14th day after CFA injection and continued until the morphine post-dose paw withdrawal latency (PWL); it did not significantly differ from the baseline. For assessment of the effects of IL-10 on tolerance induction, a neutralizing dose (ND50) of anti-IL-10 was administered daily during different stages of the study. AA induction in the right hindpaw of rats resulted in unilateral inflammation and hyperalgesia within 21 days of the study. Anti-IL-10 antibody administration in the AA rats induced marked elevation of hyperalgesia compared to the AA control group. Our data also indicated that morphine effective anti-hyperalgesic dose significantly decreased in the AA rats compared to the control group, which this symptom was aligned with spinal mu opioid receptor (mOR) expression increase during AA. Moreover, there was a significant difference in morphine tolerance induction between the AA and control rats, and our results also demonstrated that IL-10 played an important role in tolerance-induction process. It can be concluded that morphine tolerance slowly progressed when administered morphine effective dose was reduced during AA chronic inflammation. On the other hand, it seems that increased level of serum IL-10 may affect morphine tolerance development during inflammation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24643510     DOI: 10.1007/s13105-014-0330-7

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  26 in total

1.  Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats.

Authors:  Vasudeva Raghavendra; Flobert Y Tanga; Joyce A DeLeo
Journal:  Neuropsychopharmacology       Date:  2004-02       Impact factor: 7.853

Review 2.  IL-10 family of cytokines.

Authors:  Robert Sabat
Journal:  Cytokine Growth Factor Rev       Date:  2010-10       Impact factor: 7.638

3.  Phosphorylation of EEA1 by p38 MAP kinase regulates mu opioid receptor endocytosis.

Authors:  Gaëtane Macé; Marta Miaczynska; Marino Zerial; Angel R Nebreda
Journal:  EMBO J       Date:  2005-09-01       Impact factor: 11.598

4.  The effect of intrinsic efficacy on opioid tolerance.

Authors:  A Duttaroy; B C Yoburn
Journal:  Anesthesiology       Date:  1995-05       Impact factor: 7.892

5.  Regulation of p38 MAP kinase in CD4+ lymphocytes by infliximab therapy in patients with rheumatoid arthritis.

Authors:  Bruce E Garfield; Troy Krahl; Stacia Appel; Sheldon M Cooper; Mercedes Rincón
Journal:  Clin Immunol       Date:  2005-08       Impact factor: 3.969

6.  Cellular events during arthritis-induced hyperalgesia are mediated by interleukin-6 and p38 MAPK and their effects on the expression of spinal mu-opioid receptors.

Authors:  Jalal Zaringhalam; Elaheh Tekieh; Homa Manaheji; Zeinab Akhtari
Journal:  Rheumatol Int       Date:  2013-03-16       Impact factor: 2.631

7.  Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain.

Authors:  Christian Zöllner; Shaaban A Mousa; Oliver Fischer; Heike L Rittner; Mohammed Shaqura; Alexander Brack; Mehdi Shakibaei; Waltraud Binder; Florian Urban; Christoph Stein; Michael Schäfer
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

8.  Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla.

Authors:  G C Rossi; G W Pasternak; R J Bodnar
Journal:  Brain Res       Date:  1994-11-28       Impact factor: 3.252

9.  Bidirectional effects of serum TNF alpha level and spinal p38MAPK phosphorylation on hyperalgesia variation during CFA-induced arthritis.

Authors:  Zeinab Akhtari; Jalal Zaringhalam; Akram Eidi; Homa Manaheji; Elaheh Tekieh
Journal:  EXCLI J       Date:  2012-07-09       Impact factor: 4.068

10.  Increased serum IL-6 level time-dependently regulates hyperalgesia and spinal mu opioid receptor expression during CFA-induced arthritis.

Authors:  E Tekieh; Jalal Zaringhalam; H Manaheji; N Maghsoudi; B Alani; H Zardooz
Journal:  EXCLI J       Date:  2011-03-10       Impact factor: 4.068

View more
  6 in total

1.  Effects of Post-Weaning Chronic Stress on Nociception, Spinal Cord μ-Opioid, and α2-Adrenergic Receptors Expression in Rats and Their Offspring.

Authors:  Asef Hormozi; Asadollah Zarifkar; Mohsen Tatar; Mahdi Barazesh; Bahar Rostami
Journal:  J Mol Neurosci       Date:  2018-04       Impact factor: 3.444

2.  Microglial-induced apoptosis is potentially responsible for hyperalgesia variations during CFA-induced inflammation.

Authors:  Mansoureh Baniasadi; Homa Manaheji; Nader Maghsoudi; Samira Danyali; Zahra Zakeri; Amirabbas Maghsoudi; Jalal Zaringhalam
Journal:  Inflammopharmacology       Date:  2019-08-06       Impact factor: 4.473

3.  Long-Term Treatment by Vitamin B1 and Reduction of Serum Proinflammatory Cytokines, Hyperalgesia, and Paw Edema in Adjuvant-Induced Arthritis.

Authors:  Jalal Zaringhalam; Akhtar Akbari; Alireza Zali; Homa Manaheji; Vida Nazemian; Mahdi Shadnoush; Somayeh Ezzatpanah
Journal:  Basic Clin Neurosci       Date:  2016-10

Review 4.  Targeting Cytokines for Morphine Tolerance: A Narrative Review.

Authors:  Dai-Qiang Liu; Ya-Qun Zhou; Feng Gao
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

5.  Noopept; a nootropic dipeptide, modulates persistent inflammation by effecting spinal microglia dependent Brain Derived Neurotropic Factor (BDNF) and pro-BDNF expression throughout apoptotic process.

Authors:  Mona Taghizadeh; Nader Maghsoudi; Homa Manaheji; Valery Akparov; Mansoureh Baniasadi; Mola Mohammadi; Samira Danyali; Rasoul Ghasemi; Jalal Zaringhalam
Journal:  Heliyon       Date:  2021-02-12

6.  An Experimental Study on Spinal Cord µ-Opioid and α2-Adrenergic Receptors mRNA Expression Following Stress-Induced Hyperalgesia in Male Rats.

Authors:  Asef Hormozi; Asadollah Zarifkar; Bahar Rostami; Fakhraddin Naghibalhossaini
Journal:  Iran J Med Sci       Date:  2019-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.